Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

JPMorgan Global Healthcare Inclusive - Class A - Income (GBP)

Sell:25,484.00p Buy:26,893.00p Change: 556.00p (2.14%)
Prices as at 11 October 2019
Sell:25,484.00p
Buy:26,893.00p
Change: 556.00p (2.14%)
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices as at 11 October 2019
Sell:25,484.00p
Buy:26,893.00p
Change: 556.00p (2.14%)
Prices as at 11 October 2019
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Our view on this Fund

This fund does not feature on our Wealth 50 list of what we believe are the best funds in each sector. If a fund is not within our Wealth 50 this is not necessarily a recommendation to sell. However, if you are thinking of adding to your investments we believe Wealth 50 funds are superior alternatives. View funds on the Wealth 50 »

Our view on the sector

Our view on the sector for this fund is not available.

Performance Analysis

Performance analysis for this fund is not available.

Investment Philosophy

Investment philosophy for this fund is not available.

Process and Portfolio Construction

Process and portfolio construction for this fund are not available.

question mark Manager Track Record Based on HL Quantitative Research

This information is currently unavailable.

Fund Track Record

11/10/14 to 11/10/15 11/10/15 to 11/10/16 11/10/16 to 11/10/17 11/10/17 to 11/10/18 11/10/18 to 11/10/19
Annual return 12.71% 15.24% 6.70% 9.43% 1.59%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

Information about the fund

Fund manager biography

Manager Name: Anne Marden
Manager start date: 2 October 2009
Manager located in: .

Anne Marden, managing director, is a research analyst with the European Equity Research Team with responsibility for the pharmaceutical and healthcare sectors. An employee since 1986, she obtained a B.A. in economics from Princeton and earned an M.B.A. from INSEAD. She is a holder of the CFA designation.

manager photo
Manager Name: Matthew Cohen
Manager start date: 5 January 2015
Manager located in: New York

Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Matthew is responsible for research analysis and stock selection of healthcare stocks for the JPMorgan Small Cap Growth, Mid Cap Growth, and All Cap Growth Portfolios. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital - NYU School of Medicine. Matthew holds an M.B.A. from New York University's Stern School of Business and an M.D. from McGill University in Montreal.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Benchmark data provided subject to this disclaimer.
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account